Review: Intentional Weight Loss Improves Daytime Sleepiness

Share this content:
Review: Intentional Weight Loss Improves Daytime Sleepiness
Review: Intentional Weight Loss Improves Daytime Sleepiness

FRIDAY, Jan. 27, 2017 (HealthDay News) -- For overweight or obese adults, intentional weight loss is associated with improvement in daytime sleepiness, according to a review published online Jan. 24 in Obesity Reviews.

Winda L. Ng, from the Baker IDI Heart and Diabetes Institute in Melbourne, Australia, and colleagues examined the extent to which intentional weight loss affects daytime sleepiness. Data were included from 42 studies that involved overweight or obese adults, a weight loss intervention, and repeated valid measures of daytime sleepiness.

The researchers observed large improvements in daytime sleepiness in 15 before-and-after studies on surgical weight loss interventions (standardized effect size, −0.97). Small-to-moderate improvements were seen in daytime sleepiness in 27 studies on non-surgical weight loss interventions (standardized effect size, −0.40); there was no difference between controlled and before-and-after studies. The amount of weight loss was correlated in a nonlinear manner with change in daytime sleepiness.

"This review suggests that weight loss interventions improve daytime sleepiness, with a clear dose-response relationship," the authors write. "This supports the previously hypothesized causal effect of obesity on daytime sleepiness. It is important to assess and manage daytime sleepiness in obese patients."

Several authors disclosed financial ties to the pharmaceutical and nutrition industries.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »